Drugs / ChAd63 AMA1
last change Oct 2013 re-read 2 minutes ago

ChAd63 AMA1

Developed for
Plasmodium falciparum malaria

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01739036 Comparator Jan → Oct 2013 Plasmodium falciparum malaria University of Oxford Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ChAd63 AMA1 “Mixture of ChAd63 CS 5 x 1010 vp, ChAd63 ME-TRAP 5 x 1010 vp, and ChAd63 AMA1 5 x 1010 vp. Intramuscular needle injection.” NCT01739036